NetScientific PLC Result of Placing and Further Allotment of Shares (7886E)
06 Novembro 2015 - 5:00AM
UK Regulatory
TIDMNSCI
RNS Number : 7886E
NetScientific PLC
06 November 2015
THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS
RESTRICTED AND IS NOT FOR PUBLICATION, RELEASE OR DISTRIBUTION,
DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED
STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN, THE REPUBLIC OF SOUTH
AFRICA OR ANY OTHER JURISDICTION IN WHICH IT WOULD BE UNLAWFUL TO
DO SO.
THIS ANNOUNCEMENT IS NOT AN OFFER TO SELL OR THE SOLICITATION OF
AN OFFER TO BUY ANY ORDINARY SHARES OR OTHER SECURITIES OF THE
COMPANY AND NEITHER THIS ANNOUNCEMENT NOR ANYTHING HEREIN FORMS THE
BASIS FOR ANY CONTRACT OR COMMITMENT WHATSOEVER. ORDINARY SHARES OR
OTHER SECURITIES OF THE COMPANY MAY NOT BE OFFERED OR SOLD IN THE
UNITED STATES OF AMERICA ABSENT REGISTRATION OR AN EXEMPTION FROM
REGISTRATION AND THE ORDINARY SHARES DESCRIBED HEREIN WILL BE SOLD
IN ACCORDANCE WITH ALL APPLICABLE LAWS AND REGULATIONS.
6 November 2015
NetScientific plc
(the "Group")
Result of Placing and Further Allotment of New Shares Pursuant
to Offer
On 1 October 2015, the Group announced a conditional Placing to
raise approximately GBP18.0m and an Additional Fundraising to raise
up to approximately GBP2.0m, both before expenses.
The Additional Fundraising closed for acceptances at 11.00 a.m.
on 5 November 2015 and the Company is pleased to announce that it
has received valid acceptances in respect of 119,508 Additional
Fundraising Shares from Shareholders, which includes 20,833
Additional Fundraising Shares from directors of NetScientific. This
represents 7.2 per cent. of the Additional Fundraising Shares
offered. The Company has therefore raised a total of GBP18.14
million, before expenses, from the Placing and Additional
Fundraising.
The New Ordinary Shares to be issued pursuant to the Placing and
Additional Fundraising remain subject to the passing of the
Resolutions at the General Meeting to be held at the offices of
Simmons & Simmons, CityPoint, 1 Ropemaker Street, London EC2Y
9SS at 9.00 a.m. today and Admission (as defined below).
Capitalised terms in this announcement have the meanings given
to them in the Circular dated 21 October 2015.
Applications have been made to the London Stock Exchange for New
Ordinary Shares to be admitted to trading on AIM ("Admission").
Admission is expected to commence at 8.00 am on 9 November 2015.
Following Admission, the New Ordinary Shares will rank pari passu
with the existing Ordinary Shares.
On Admission, the Company's issued share capital will comprise
51,021,528 Ordinary Shares, none of which will be held in treasury.
Each Ordinary Share carries the right to one vote and therefore the
total number of voting rights in the Company on admission will be
51,021,528. This figure may be used by shareholders and other
investors as the denominator for the calculations by which they
will determine if they are required to notify their interest in, or
change to their interest in, the Company under the FCA's Disclosure
and Transparency Rules
A copy of this announcement is also available on the Company's
website at www.netscientific.net.
Directors' interests
Mr. Barry Wilson, a Director of the Company, participated in the
Additional Fundraising and following admission of the New Ordinary
Shares allotted under the Placing and Additional Fundraising, his
interest, and the interest of the other Directors, in the Ordinary
Shares of the Company will be as follows:
Director Number of Ordinary % share capital prior Number of New % Enlarged Share
Shares held prior to to Admission Ordinary Shares Capital
Admission immediately
following Admission
----------------------- ---------------------- ---------------------- --------------------- ----------------------
Richard Sykes 62,500 0.17% 62,500 0.12%
----------------------- ---------------------- ---------------------- --------------------- ----------------------
Dr. Michael
Boyce-Jacino 1,563 0.00% 1,563 0.00%
----------------------- ---------------------- ---------------------- --------------------- ----------------------
David Gough 6,250 0.02% 6,250 0.01%
----------------------- ---------------------- ---------------------- --------------------- ----------------------
Peter Thoms 1,563 0.00% 1,563 0.00%
----------------------- ---------------------- ---------------------- --------------------- ----------------------
Barry Wilson 15,525 0.04% 36,358 0.07%
----------------------- ---------------------- ---------------------- --------------------- ----------------------
Contact Details
NetScientific plc Tel: +44 (0)20
3514 1800
François Martelet, CEO
Peter Thoms, CFO
Investec Bank plc (NOMAD, Broker Tel: +44 (0)20
and joint bookrunner in connection 7597 4000
with the placing)
Gary Clarence
Daniel Adams
Liberum Capital (joint bookrunner Tel: +44 (0)
in connection with the placing) 20 3100 2000
Christopher Britton
Instinctif Partners Tel: +44 (0)20 7457 2020
Melanie Toyne-Sewell or
/ Jayne Crook netscientific@instinctif.com
Investec Bank plc, which is authorised in the United Kingdom by
the Prudential Regulatory Authority and regulated by the FCA and
the Prudential Regulatory Authority, is acting exclusively for the
Company and no other person in connection with the Placing.
Investec Bank plc is not acting for the Company or anyone else in
connection with the Additional Fundraising. Investec Bank plc's
responsibilities as the Company's nominated adviser under the AIM
Rules for Nominated Advisers are owed solely to the London Stock
Exchange and are not owed to the Company or to any Director or to
any person in respect of his decision to acquire Placing Shares or
Additional Fundraising Shares in reliance on any part of this
document. No representation or warranty, express or implied, is
made by Investec Bank plc about any of the contents of this
document and, without limiting the statutory rights of any person
to whom this document is issued, no liability whatsoever is
accepted by Investec Bank plc for the accuracy of any information
or opinions contained in this document or for the omission of any
material information. Investec Bank plc will not be offering advice
nor will it be responsible for providing client protections to
recipients of this document in respect of the Placing and
Additional Fundraising.
Liberum Capital Limited, which is authorised and regulated in
the United Kingdom by the FCA, is acting exclusively for the
Company and no other person in connection with the Placing. Liberum
Capital Limited is not acting for the Company or anyone else in
connection with the Additional Fundraising. No representation or
warranty, express or implied, is made by Liberum Capital Limited
about any of the contents of this document and, without limiting
the statutory rights of any person to whom this document is issued,
no liability whatsoever is accepted by Liberum Capital Limited for
the accuracy of any information or opinions contained in this
document or for the omission of any material information. Liberum
Capital Limited will not be offering advice nor will it be
responsible for providing client protections to recipients of this
document in respect of the Placing and Additional Fundraising.
This information is provided by RNS
The company news service from the London Stock Exchange
END
IOEDXBDBDXGBGUU
(END) Dow Jones Newswires
November 06, 2015 02:00 ET (07:00 GMT)
Netscientific (LSE:NSCI)
Gráfico Histórico do Ativo
De Jun 2024 até Jul 2024
Netscientific (LSE:NSCI)
Gráfico Histórico do Ativo
De Jul 2023 até Jul 2024
